Characteristics of Blood- Brain Barrier Permeability in Neurological Patients

NCT00419874 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2007-01-09

No results posted yet for this study

Summary

The main goal of the present study is to challenge the hypothesis that blood- brain barrier disruption following brain injury increases the risk for long-term disability, development of brain dysfunction, epileptic seizures and neuroanatomical alterations.

Conditions

Sponsors & Collaborators

  • Soroka University Medical Center

    lead OTHER

Principal Investigators

  • Alon Friedman, MD/PhD · Soroka University Medical Center

  • Ilan Shelef, MD · Soroka University Medical Center

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00419874 on ClinicalTrials.gov